CD8A and Fulminant hepatitis: We have established a preclinical murine model for fulminant hepatitis using recombinant adenoviruses that target hepatocytes36 similar to hepatotropic hepatitis viruses and the high-affinity TCR OT-I system that reflects the high-affinity virus-specific CD8 T cells found during acute viral hepatitis37.